By John Hassell | National Director of Advocacy – AIDS Healthcare Foundation Despite the drug industry’s best efforts, at a March 15, 2018 hearing on the 340B Drug Pricing Program in the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee, a majority of the senators who spoke made the case that the 340B program is working as intended and … Read More
Don’t be “Phooled” by PhRMA
The 340B Drug Program’s intent is to help safety-net providers “stretch scarce federal resources” to provide more and better services to their clients. The 340B program is saving lives while pharma corporate interests are blaming it for high drug prices. Help save the 340B program from sneak attacks. Save the safety net. Protect and defend the 340B Drug Program. Why … Read More
340B Is Up for Review and Needs Your Help
Amid the many issues Congress has on its agenda, 340B is being pushed to the forefront because of the drug industry’s lobbying efforts. The 340B Drug Pricing Program will be up for review in the U.S. Senate’s Health, Education, Labor and Pensions (HELP) Committee hearing on Thursday, March 15. Advocates for 340B have been going to both congressional offices on Capitol … Read More
New Analysis Shows 340B Tax-Exempt Hospitals Provided More Than $50 Billion in Total Benefits to Their Communities
By The American Hospital Association WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the American Hospital Association (AHA) spotlights how 340B tax-exempt hospitals provided more than $50 billion in total benefits to their communities in 2015 alone, the most recent year for which data is available. … Read More